Evidence map›Paper›PMID 37780700›Full record

ArticleFrontiers in neurology2023

SIGMAR1 variants in ALS-PD complex cases: a case report of a novel mutation and literature review.

Haining Li, Tingting Xuan, Ting Xu, Juan Yang, Jiang Cheng, Zhenhai Wang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. BiallelicJournal of neuromuscular diseases · 2026
    Article
  3. Review
  4. A novelFrontiers in genetics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Haining LiDepartment of Neurology, General Hospital of Ningxia Medical University, Yinchuan, China.
Tingting XuanDepartment of Neurology, General Hospital of Ningxia Medical University, Yinchuan, China.
Ting XuDepartment of Neural Electrophysiology, Cardiovascular and Cerebrovascular Disease Hospital, General Hospital of Ningxia Medical University, Yinchuan, China.
Juan YangDepartment of Neurology, General Hospital of Ningxia Medical University, Yinchuan, China.
Jiang ChengDepartment of Neurology, General Hospital of Ningxia Medical University, Yinchuan, China.
Zhenhai WangInstitute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Ningxia Medical University · CNNingxia Medical University General Hospital · CNThe Fourth People's Hospital of Ningxia Hui Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive degeneration of upper and lower motor neurons, with occasional involvement of the extrapyramidal system. Mutations in the sigma non-opioid intracellular receptor 1 (

Indexed as

amyotrophic lateral sclerosisgenotypeParkinson’s diseasephenotypeSIGMAR1

Identifiers

PMID37780700
PMCPMC10533989
OpenAlexW4386698469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.